The Professional Relations Committee (PRC) invites you to participate in a conversation about the past, present and future advocacy efforts focused on the ability of Board-certified doctoral clinical laboratory professionals to bill CMS under the physician fee schedule (PFS) for their role in performing, interpreting, and reporting individual results for molecular diagnostic tests. AMP has long been an advocate for qualified doctoral clinical laboratory professionals to bill on the PFS and in late 2018, AMP reignited our advocacy in this area through the creation of the Professional Reimbursement Workgroup (a joint workgroup of the PRC and the Economic Affairs Committee, EAC). The workgroup is charged with developing and proposing potential coding solutions for the interpretive work involved with molecular tests as well as ensuring that qualified doctoral clinical laboratory professionals will also be able to bill for this work. This year, the workgroup launched a landscape analysis of the interpretive work that is performed by both molecular pathologists and clinical laboratory professionals. During the session, the workgroup reported on the results of this study and their next advocacy steps. Additionally, the AMP workgroup was joined by representatives from the American College of Medical Genetics and Genomics (ACMG), who also reignited their advocacy in this area by releasing a statement on “PhDs as Qualified Healthcare Professionals” in late 2019. Please watch this discussion about AMP and ACMG’s current advocacy activities in this area and learn how AMP members can get more involved in furthering this mission.
The Roadmap to Recognition of Molecular Professionals as Qualified Healthcare Professionals
Andrea Ferreira-Gonzalez, PhD, VCU Heath, Richmond, VA, USA
Elaine Lyon, PhD, HudsonAlpha Institute for Biotechnology, Huntsville, AL, USA
Christina Lockwood, PhD, University of Washington, Seattle, WA, USA
John Schmitz, PhD, D(ABHI, ABMLI), F(AAM), UNC School of Medicine, Chapel Hill, NC, USA
Objectives:
- Understand the CMS billing for professional and interpretive work and explain previous efforts by AMP and others on this topic.
- Gain a clear perspective of AMP’s landscape analysis and understand the gaps between the interpretive work involved with molecular pathology testing and the current reimbursement structure.
- Comprehend the history on this issue and concerns for various professional organizations.
- Learn key ways one can get more involved in this issue.
Recording Date: November 19, 2020
Continuing Education Credit Information
CME/CMLE credit: 1.50 hr
Last day to purchase course and CE claim credit: February 16, 2024
Note: Members of AMP can access this at a discount. Join the AMP Family!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.
